Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-060504
Filing Date
2021-10-14
Accepted
2021-10-14 18:33:08
Documents
1
Period of Report
2021-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5902
  Complete submission text file 0001209191-21-060504.txt   7253
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Dier Mardi (Reporting) CIK: 0001574591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 211324419